{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:25:28Z","timestamp":1790112328337,"version":"4.0.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.autrev.2014.05.009","type":"journal-article","created":{"date-parts":[[2014,5,29]],"date-time":"2014-05-29T07:45:12Z","timestamp":1401349512000},"page":"1142-1148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["A hyper-ferritinemia syndrome evolving in recurrent macrophage activation syndrome, as an onset of amyopathic juvenile dermatomyositis: A challenging clinical case in light of the current diagnostic criteria"],"prefix":"10.1016","volume":"13","author":[{"given":"Dimitri","family":"Poddighe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Cavagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Brazzelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Bruni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Luigi","family":"Marseglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2014.05.009_bb0005","series-title":"Textbook of Pediatric Rheumatology","first-page":"375","article-title":"Juvenile dermatomyositis","author":"Rider","year":"2011"},{"key":"10.1016\/j.autrev.2014.05.009_bb0010","series-title":"Handbook of Clinical Neurology","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/B978-0-444-59565-2.00014-9","article-title":"Juvenile dermatomyositis","author":"Quartier","year":"2013"},{"key":"10.1016\/j.autrev.2014.05.009_bb0015","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.pcl.2005.01.004","article-title":"Inflammatory myopathies in children","volume":"52","author":"Compeyrot-Lacassagne","year":"2005","journal-title":"Pediatr Clin N Am"},{"key":"10.1016\/j.autrev.2014.05.009_bb0020","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s11926-011-0167-9","article-title":"Juvenile dermatomyositis","volume":"13","author":"Batthish","year":"2011","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.autrev.2014.05.009_bb0025","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/1756-185X.12107","article-title":"Clinical features and disease course of patients with juvenile dermatomyositis","volume":"16","author":"Gowdie","year":"2013","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2014.05.009_bb0030","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2165\/10899380-000000000-00000","article-title":"Juvenile-onset clinically amyopathic dermatomyositis","volume":"12","author":"Walling","year":"2010","journal-title":"Pediatr Drugs"},{"issue":"2","key":"10.1016\/j.autrev.2014.05.009_bb0035","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00431-006-0258-1","article-title":"Familial and acquired hemophagocytic lymphohistiocytosis","volume":"166","author":"Janka","year":"2007","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.autrev.2014.05.009_bb0040","first-page":"633","article-title":"The hemophagocytic syndrome\/macrophage activation syndrome: a final common pathway of a cytokine storm","volume":"11","author":"Szyper-Kravitz","year":"2009","journal-title":"IMAJ"},{"key":"10.1016\/j.autrev.2014.05.009_bb0045","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.blre.2007.05.001","article-title":"Hemophagocytic syndromes","volume":"21","author":"Janka","year":"2007","journal-title":"Blood Rev"},{"key":"10.1016\/j.autrev.2014.05.009_bb0050","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1586\/eci.09.58","article-title":"Primary and secondary hemophagocytic lymphohistiocytosis: clinical features, pathogenesis and therapy","volume":"6","author":"Gupta","year":"2010","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.autrev.2014.05.009_bb0055","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"Arico' M, Egeler RM, Filipovich AH, Imashuku S, Ladish S, McClain K, Webb D, Winiarski J, Janka G. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.autrev.2014.05.009_bb0060","first-page":"1414","article-title":"Haemophagocytic syndrome in rheumatic patients: a systematic review","volume":"16","author":"Atteritano","year":"2012","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.autrev.2014.05.009_bb0065","first-page":"1","article-title":"A fatal case of acquired hemophagocytic lymphohistiocytosis (macrophage activation syndrome) in the initial course of dermatomyositis with anti-Jo1 antibody","volume":"X","author":"Bazan-Socha","year":"2013","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.autrev.2014.05.009_bb0070","first-page":"1014","article-title":"Macrophage activation syndrome due to methotrexate in 12years old boy with dermatomyositis","volume":"31","author":"Sterba","year":"2004","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2014.05.009_bb0075","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3109\/03009742.2013.863968","article-title":"Severe macrophage activation syndrome and central nervous system involvement in juvenile dermatomyositis","volume":"43","author":"Lilleby","year":"2013","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2014.05.009_bb0080","first-page":"1133","article-title":"Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis","volume":"34","author":"Behrens","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2014.05.009_bb0085","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s10067-013-2227-1","article-title":"Recurrent macrophage activation syndrome as the primary manifestation in systemic lupus erythematosus and the benefit of serial ferritin measurements: a case-based review","volume":"32","author":"Vilaiyuk","year":"2013","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2014.05.009_bb0090","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1002\/art.24883","volume":"60","author":"Parodi","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2014.05.009_bb0095","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s10067-012-1998-0","article-title":"Clinical analysis of macrophage activation syndrome in pediatric patients with autoimmune diseases","volume":"31","author":"Lin","year":"2012","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2014.05.009_bb0100","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jpeds.2004.12.016","article-title":"Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis","volume":"146","author":"Ravelli","year":"2005","journal-title":"J Pediatr"},{"key":"10.1016\/j.autrev.2014.05.009_bb0105","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/BOR.0b013e32825a6a79","article-title":"Recognition and management of macrophage activation syndrome in juvenile arthritis","volume":"19","author":"Kelly","year":"2007","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2014.05.009_bb0110","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.jpeds.2012.11.081","article-title":"Differentiating macrophage activation syndrome in systemic juvenile idiopathic arthritis from other forms of hemophagocytic lymphohistiocytosis","volume":"162","author":"Lehmberg","year":"2013","journal-title":"J Pediatr"},{"key":"10.1016\/j.autrev.2014.05.009_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/535738","article-title":"Epstein\u2013Barr virus in systemic autoimmune diseases","author":"Draborg","year":"2013","journal-title":"Clin Dev Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2014.05.009_bb0120","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1080\/08916930802024772","article-title":"Regulation and dysregulation of Epstein\u2013Barr virus latency: implications for the development of autoimmune diseases","volume":"41","author":"Niller","year":"2008","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2014.05.009_bb0125","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/rmv.638","article-title":"Viral infections associated with haemophagocytic syndrome","volume":"20","author":"Maakaroun","year":"2010","journal-title":"Rev Med Virol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997214001281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997214001281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T20:21:56Z","timestamp":1538598116000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997214001281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S1568997214001281"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2014.05.009","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A hyper-ferritinemia syndrome evolving in recurrent macrophage activation syndrome, as an onset of amyopathic juvenile dermatomyositis: A challenging clinical case in light of the current diagnostic criteria","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2014.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}